Dr. Cosmin Tegla, MD

  • New York, NY
  • Medical oncologist
NPI1124420583PAC ID3779968300
Medicare services, 2024
410
Medicare patients, 2024
181
Part D claims, 2024
192
Publications
16
MIPS score, 2024
91
Practice address
14 Wall St, New York, NY 10005
Practice phone
Call (212) 263-1481
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

NYU Langone Perlmutter Cancer Center - 34th St

New York, New York

See all 3 affiliations

Find Dr. Tegla's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Cosmin Tegla is a medical oncologist in New York, New York

Dr. Tegla practices at NYU Langone Perlmutter Cancer Center - 34th St in New York, New York.

Dr. Tegla's NPI, 1124420583, was assigned on September 17, 2014. Dr. Tegla graduated from Iuliu Hatieganu University of Medicine and Pharmacy in 2006. Dr. Tegla holds New York license 289964.

NPI and contact details
Medicare PAC ID
3779968300
NPI enumeration date
September 17, 2014
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(212) 263-1481
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
46
Medical school graduation
2006

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Cosmin Tegla practices at NYU Langone Perlmutter Cancer Center - 34th St in New York, New York

Dr. Tegla's primary practice is NYU Langone Perlmutter Cancer Center - 34th St, at 14 Wall St, New York, NY 10005 in New York County. The practice phone is (212) 263-1481.

  • NYU Langone Perlmutter Cancer Center - 34th St
    14 Wall St, New York, NY 10005 · New York CountyPhone(212) 263-1481

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Cosmin Tegla is affiliated with 2 sites of care and 1 medical group

Dr. Tegla's primary practice is NYU Langone Perlmutter Cancer Center - 34th St in New York, New York. Dr. Tegla is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates.

See all 3 affiliations for Dr. Tegla

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Cosmin Tegla's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tegla practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
NYU Langone Perlmutter Cancer Center - 34th StAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Tegla practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Cosmin Tegla is one of 458 medical oncologists in New York

Medical oncology is Dr. Tegla's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Tegla is board certified in hematology by the American Board of Internal Medicine. Dr. Tegla is licensed in New York.

Specialties and state licenses

  • Medical oncology, New YorkPrimaryLicense 289964 · taxonomy 207RX0202X

Medical oncologists near Dr. Tegla

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Cosmin Tegla billed Medicare for 410 services in 2024

CMS data shows 410 Medicare services from Dr. Tegla across 7 procedure codes in 2024, for 181 Medicare patients. Medicare paid $29,730 for them.

Medicare services, 2024410
Medicare patients181
Paid by Medicare$29,730
Procedure codes7

Dr. Tegla's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 3632024: 41013%
Surgery
2023: 502024: 0100%

Where Dr. Tegla's Medicare services took place, 2024

  • In an office30474%
  • In a facility10626%

Dr. Tegla compared with the New York median for medical oncologists, 2024

  • Dr. Tegla
  • New York median
Medicare services
410vs 34021% above
Medicare patients
181vs 11262% above
Part D claims
130vs 130Close to median

Medians across 421 medical oncologists in New York with Dmand AI profiles that report each measure.

Dr. Tegla's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Tegla

Need commercial claims for Dr. Tegla?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Tegla and other medical oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Cosmin Tegla treated 181 Medicare patients in 2024, average age 73

CMS counts 181 Medicare patients who saw Dr. Tegla in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tegla's median patient age at 59, with 51% women.

Medicare patients, 2024181
Average age73
Average risk score2.27
Also on Medicaid28%

Dr. Tegla's Medicare patients by age, 2024

Dr. Tegla's Medicare patients by sex, 2024

  • Women8346%
  • Men9854%

Chronic conditions among Dr. Tegla's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis60%
  4. Ischemic heart disease52%
  5. Diabetes43%
  6. Anxiety38%
  7. Chronic kidney disease38%
  8. Mood disorders33%

Share of Medicare patients with each condition. A patient can have several.

Dr. Tegla's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 59

Patient panel by sex, all payers

  • Women51%
  • Men45%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Cosmin Tegla wrote 192 Medicare Part D claims in 2024

In 2024, Dr. Tegla wrote 192 Medicare Part D claims for 33 patients. 57% of them were for generic drugs. CMS names the drug for 130 of them, across 7 drugs with 11 or more claims each, at $1,190,518 in total drug cost. In 2023, CMS named 130 claims across 5 drugs.

Part D claims, 2024192
Drugs named by CMS7
Total drug cost$1.2M
Part D patients33

Dr. Tegla's Part D claims by kind of drug, 2024

  • Generic109 claims57%
  • Brand-name83 claims43%

Dr. Tegla's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Tegla's Part D claims, 2024

  • Antibiotics8%15 of 192 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1302024: 130No change

Drugs named by CMS: 7 in 2024, 5 in 2023.

See all prescribing by Dr. Tegla

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Cosmin Tegla scored 91 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Tegla for performance year 2024, reported as part of a group. Dr. Tegla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tegla as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Tegla's MIPS scores, performance year 2024

  • 91of 100Final score
  • 91.8of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 75of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Tegla by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Cosmin Tegla has 16 publications on record

Dmand AI links 16 papers to Dr. Tegla, published from 2011 to 2024. 2012 was the busiest year, with 2. The most frequent topics are Cell Cycle Proteins, Multiple Sclerosis and Muscle Proteins. Dr. Tegla has published most often in Exp Mol Pathol. Dr. Tegla's most frequent co-authors are Violeta Rus, MD, Cornelia Diana Cudrici, MD and Adam Mika Kruszewski, MD.

Papers16
Years published2011 to 2024

Dr. Tegla's papers by year, 2011 to 2024

Topics Dr. Tegla writes about most

  • Cell Cycle Proteins
  • Multiple Sclerosis
  • Muscle Proteins
  • Nerve Tissue Proteins
  • RNA, Messenger
  • Apoptosis
  • Cell Cycle
  • Cell Differentiation

Dr. Tegla's most frequent co-authors

Recent publications by Dr. Tegla

See all 16 publications and co-authors

See who Dr. Tegla researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Tegla works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Cosmin Tegla received $413 in industry payments from 2022 to 2024

CMS Open Payments shows 4 general payments to Dr. Tegla from 3 drug and device companies from 2022 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $260.

General payments to Dr. Tegla by program year, 2022 to 2024

Companies that paid Dr. Tegla the most, 2022 to 2024

Share is of all general payments to this clinician.

See all payments to Dr. Tegla

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Cosmin Tegla graduated from Iuliu Hatieganu University of Medicine and Pharmacy

Dr. Tegla graduated from Iuliu Hatieganu University of Medicine and Pharmacy in 2006.

  1. Medical schoolIuliu Hatieganu University of Medicine and Pharmacy
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in internal medicineAmerican Board of Internal Medicine
  4. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Cosmin Tegla's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Cosmin Tegla

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Cosmin Tegla's NPI number?

Dr. Cosmin Tegla's NPI number is 1124420583. It was assigned on September 17, 2014, and it is active in the NPI Registry.

What kind of doctor is Dr. Cosmin Tegla?

Dr. Cosmin Tegla is a medical oncologist in New York, New York. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Cosmin Tegla practice?

Dr. Tegla practices at 14 Wall St, New York, NY 10005. Dr. Tegla's primary practice is NYU Langone Perlmutter Cancer Center - 34th St in New York, New York.

What is Dr. Cosmin Tegla's office phone number?

The practice phone on file for Dr. Tegla is (212) 263-1481.

What is Dr. Cosmin Tegla's medical license number?

Dr. Tegla holds New York license 289964.

Which hospitals is Dr. Cosmin Tegla affiliated with?

Dr. Tegla is affiliated with Tisch Hospital.

What medical group is Dr. Cosmin Tegla part of?

Dr. Tegla is linked to NYU Langone Orthopedic Surgery Associates.

Does Dr. Cosmin Tegla accept Medicare?

Yes. CMS data shows Dr. Tegla billed Medicare for 410 services in 2024, and Dr. Tegla accepts Medicare assignment.

Does Dr. Cosmin Tegla offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Tegla as offering telehealth services.

What is Dr. Cosmin Tegla's MIPS score?

Dr. Tegla's MIPS final score for performance year 2024 is 91 out of 100, reported as part of a group.

Show 9 more questionsShow fewer questions

How many Medicare patients does Dr. Cosmin Tegla see?

CMS counts 181 Medicare patients who saw Dr. Tegla in 2024, with an average age of 73.

Is Dr. Cosmin Tegla board certified?

Yes. Dr. Tegla is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Cosmin Tegla bill to Medicare?

In 2024, Dr. Tegla's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99213) and hospital inpatient care (99232).

Where did Dr. Cosmin Tegla go to medical school?

Dr. Tegla graduated from Iuliu Hatieganu University of Medicine and Pharmacy in 2006.

What drugs does Dr. Cosmin Tegla prescribe most?

In 2024 Medicare Part D data, Dr. Tegla's most prescribed drugs by claims were Imbruvica, Acyclovir and Prednisone.

Has Dr. Cosmin Tegla received payments from drug or device companies?

CMS Open Payments shows $413 in general payments to Dr. Tegla from 3 companies from 2022 to 2024. The largest total came from Abbvie Inc.

How long has Dr. Cosmin Tegla been practicing?

Dr. Tegla graduated from medical school in 2006, 20 years ago.

Does Dr. Cosmin Tegla do research?

Dmand AI links 16 publications to Dr. Tegla, published from 2011 to 2024.

Who does Dr. Cosmin Tegla publish with?

Dr. Tegla's most frequent co-authors are Violeta Rus, MD (12 shared papers), Cornelia Diana Cudrici, MD (10 shared papers) and Adam Mika Kruszewski, MD (4 shared papers).

Selling to medical oncology practices?

See medical oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)